Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kerala AyurvedaBOM:530163 -3.47%47 Days Payable is 213.17 as of Jun. 2026, which is 101% above its 10-year median of 105.91. GuruFocus rates BOM:530163 with a GF Score™ of 47/100 and a GF Value™ of ₹352.42 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 925 Drug Manufacturers companies, Kerala Ayurveda ranks better than 64.76% on this metric.
The historical rank and industry rank for Kerala Ayurveda's Days Payable or its related term are showing as below:
BOM:530163'
s Days Payable Range Over the Past 10 Years
Min: 79.93 Med: 105.91 Max: 136.5
Current: 116.3
During the past 13 years, Kerala Ayurveda's highest Days Payable was 136.50. The lowest was 79.93. And the median was 105.91.
BOM:530163's Days Payable is ranked better than 64.76% of 925
companies
in the Drug Manufacturers industry
Industry Median: 88.85
vs BOM:530163: 116.30
Kerala Ayurveda's Days Payable
increased
from Jun. 2025 (75.89) to Jun. 2026 (213.17).
It may suggest that Kerala Ayurvedadelayed paying its suppliers.
The historical data trend for Kerala Ayurveda's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Kerala Ayurveda's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kerala Ayurveda Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kerala Ayurveda's Days Payable distribution charts can be found below:
* The bar in red indicates where Kerala Ayurveda's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Kerala Ayurveda's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kerala Ayurveda (BOM:530163) has a Days Payable of 213.17 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kerala Ayurveda and its competitors. This is 101% above median its historical median of 105.91. Over the past decade, Kerala Ayurveda's Days Payable has ranged from 79.93 to 136.50. According to the industry distribution chart, Kerala Ayurveda ranks #326 out of 925 companies in the Drug Manufacturers industry, placing it in the top 35.2%.
Is Kerala Ayurveda's Days Payable too high?
Kerala Ayurveda's current Days Payable of 213.17 is 101% above median its 10-year median of 105.91. Over the past 10 years, this metric has ranged from a low of 79.93 to a high of 136.50. The Drug Manufacturers industry median Days Payable is 88.85. Kerala Ayurveda's value of 213.17 is 139.9% above this industry median. Based on the distribution chart, Kerala Ayurveda ranks #326 out of 925 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Kerala Ayurveda has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kerala Ayurveda's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Kerala Ayurveda ranks #326 out of 925 companies for Days Payable. This puts Kerala Ayurveda in the upper half of its industry. The industry median Days Payable is 88.85. Kerala Ayurveda's value of 213.17 is 139.9% above this benchmark. Historically, Kerala Ayurveda's own Days Payable has ranged from 79.93 to 136.50 over the past decade. While the company's 10-year median is 105.91 vs. the industry median of 88.85, Kerala Ayurveda has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.85, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kerala Ayurveda's current Days Payable of 213.17 is 139.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kerala Ayurveda and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kerala Ayurveda's current Days Payable is 213.17, which is 101% above median its own 10-year median of 105.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kerala Ayurveda stock overvalued right now?
Based on GuruFocus' analysis, Kerala Ayurveda (BOM:530163) is currently considered Possible Value Trap. The stock's GF Value™ is ₹352.42, compared to a current price of ₹172.35 — trading 51.1% below its estimated fair value. The current Days Payable is 213.17, which is 101% above median its 10-year median of 105.91 and 139.9% above the Drug Manufacturers industry median of 88.85. Kerala Ayurveda's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Kerala Ayurveda (BOM:530163), the current Days Payable is 213.17 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kerala Ayurveda (BOM:530163) Overvalued in 2026?
Based on GuruFocus' analysis, Kerala Ayurveda stock appears to be undervalued.
The current stock price of ₹172.35 is trading 51.1% below its estimated GF Value™ of ₹352.42.
GuruFocus considers Kerala Ayurveda to be Possible Value Trap.
Key valuation signals for BOM:530163:
Days Payable: 213.17 (101% above median its 10-year median of 105.91)
GF Value™: ₹352.42 vs. price of ₹172.35 (51.1% below fair value)
Industry Position: 139.9% above the Drug Manufacturers median (#326 of 925)
No single metric tells the full story. See the BOM:530163 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kerala Ayurveda Ltd is engaged in producing and selling ayurvedic products and providing healthcare services. The company offers ayurvedic medicine products for diabetes and heart health, skin and hair care, kids' health, women's care, men's care, gastro care, respiratory and allergy, general healthcare, massage oils, renal care, and joint care. It provides services through wellness clinics, resorts, hospitals, and academies. The company has only one reportable business segment, i.e., Full-spectrum Ayurvedic wellness. It generates maximum revenue from the sale of products. Geographically, the company generates maximum revenue from its business in India and also has some exposure to other markets.
47GF Score
Get the complete analysis for BOM:530163
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530163 has been successfully added to your 
